Sunshine Biopharma Inc. Current Liabilities
Sunshine Biopharma Inc. (SBFM) had Current Liabilities of $5.62 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $5.62M.
- 2026-03-31: Liabilities, Current $5.88M.
- 2025-12-31: Liabilities, Current $6.44M.
- 2025-09-30: Liabilities, Current $6.65M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.62M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.88M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $6.44M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.65M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.57M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.76M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $6.31M 10-K · filed 2026-04-03 | |
| 2024-09-30 | $4.53M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $5.30M 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | $6.53M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $5.55M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $5.09M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.66M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $6.91M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $6.93M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $480.21K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $104.68K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $95.23K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $91.23K 10-K · filed 2023-04-04 | |
| 2021-09-30 | $471.63K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $635.56K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $864.79K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.05M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $747.85K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $602.55K 10-Q/A · filed 2020-08-31 | $686.20K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $772.29K 10-Q · filed 2020-05-18 | |
| 2019-12-31 | $833.53K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $889.19K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $925.69K 10-Q · filed 2019-08-15 | |
| 2019-03-31 | $1.12M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $912.48K 10-K · filed 2020-05-01 | |
| 2018-09-30 | $747.13K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $1.14M 10-Q · filed 2018-08-17 | |
| 2018-03-31 | $1.18M 10-Q · filed 2018-05-22 | |
| 2017-12-31 | $751.14K 10-K · filed 2019-04-12 | |
| 2017-09-30 | $609.87K 10-Q · filed 2017-11-15 | |
| 2017-06-30 | $780.62K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $284.45K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $274.10K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $276.68K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.21M 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $1.19M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.27M 10-K · filed 2017-04-17 | |
| 2015-09-30 | $469.57K 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $531.00K 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |